AppGenex Diagnostics, Inc.

AppGenex Diagnostics develops multiplexed diagnostic products for the detection of diseases caused by infectious pathogens.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Mountain View, CA, USA
  • Currency USD
  • Founded January 2011
  • Incorporation Type C-corp
  • Website appgenex.com

Company Summary

AppGenex Diagnostics, Inc. develops and provides multiplexed products for diagnosis of infectious disease. The Company’s strategic focus is on unmet diagnostic need of human diseases, such as tuberculosis (TB), affecting the developing world. Our main product is a TB Detection Panel intended as a first-line test for use in clinics with high TB patient volumes.

Team

  • Stephen Dunn
    CEO and Co-Founder

    Former Director of Virology at PPD Discovery, Inc. and former CEO and Co-Founder at Avatar Vaccines, Inc.

  • Paul A. Luciw
    Co-Founder

    Professor Emeritus, Dept. of Pathology and Laboratory Medicin, UC Davis

  • Imran Khan
    Co-Founder

    Professor, Dept. of Pathology and Laboratory Medicine, UC Davis

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free